My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 101

1.

Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy.

Gruden G, Bruno G, Chaturvedi N, Burt D, Schalkwijk C, Pinach S, Stehouwer CD, Witte DR, Fuller JH, Perin PC; EURODIAB Prospective Complications Study Group.

Diabetes. 2008 Jul;57(7):1966-70. Epub 2008 Apr 4.PMID: 18390793 [PubMed - indexed for MEDLINE]Related articlesFree article

2.

Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.

Crook MA, Pickup JC, Lumb PJ, Giorgino F, Webb DJ, Fuller JH; EURODIAB IDDM Complications Study Group.

Diabetes Care. 2001 Feb;24(2):316-22. Erratum in: Diabetes Care 2001 May;24(5):973. Georgino, F [corrected to Giorgino, F]. PMID: 11213885 [PubMed - indexed for MEDLINE]Related articlesFree article

3.

Anti-heat shock protein 27 antibody levels and diabetes complications in the EURODIAB study.

Burt D, Bruno G, Chaturvedi N, Schalkwijk C, Stehouwer CD, Witte DR, Fuller JH, Pinach S, Perin PC, Gruden G.

Diabetes Care. 2009 Jul;32(7):1269-71. Epub 2009 Apr 14.PMID: 19366969 [PubMed - indexed for MEDLINE]Related articlesFree article

4.

ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study.

Gruden G, Bruno G, Chaturvedi N, Burt D, Pinach S, Schalkwijk C, Stehouwer CD, Witte DR, Fuller JH, Cavallo-Perin P; EURODIAB Prospective Complications Study Group.

J Intern Med. 2009 Dec;266(6):527-36. Epub 2009 May 8.PMID: 19563392 [PubMed - in process]Related articles

5.

Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.

Soedamah-Muthu SS, Chaturvedi N, Teerlink T, Idzior-Walus B, Fuller JH, Stehouwer CD; Eurodiab ProspectivE Complications Study Group.

J Intern Med. 2005 Nov;258(5):450-9.PMID: 16238681 [PubMed - indexed for MEDLINE]Related articles

6.

Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes.

Jenkins AJ, Zhang SX, Rowley KG, Karschimkus CS, Nelson CL, Chung JS, O'Neal DN, Januszewski AS, Croft KD, Mori TA, Dragicevic G, Harper CA, Best JD, Lyons TJ, Ma JX.

Diabet Med. 2007 Dec;24(12):1345-51. Epub 2007 Oct 29.PMID: 17971181 [PubMed - indexed for MEDLINE]Related articles

7.

Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes.

Jaffa AA, Durazo-Arvizu R, Zheng D, Lackland DT, Srikanth S, Garvey WT, Schmaier AH; DCCT/EDIC Study Group.

Diabetes. 2003 May;52(5):1215-21.PMID: 12716755 [PubMed - indexed for MEDLINE]Related articlesFree article

8.

Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.

Berg TJ, Snorgaard O, Faber J, Torjesen PA, Hildebrandt P, Mehlsen J, Hanssen KF.

Diabetes Care. 1999 Jul;22(7):1186-90.PMID: 10388987 [PubMed - indexed for MEDLINE]Related articlesFree article

9.

Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study.

Schram MT, Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study.

Diabetes Care. 2003 Jul;26(7):2165-73.PMID: 12832330 [PubMed - indexed for MEDLINE]Related articlesFree article

10.

Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.

Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P, Nawroth PP.

Diabetes Care. 1998 May;21(5):841-8.PMID: 9589252 [PubMed - indexed for MEDLINE]Related articlesFree article

11.

YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.

Rathcke CN, Persson F, Tarnow L, Rossing P, Vestergaard H.

Diabetes Care. 2009 Feb;32(2):323-8. Epub 2008 Oct 28.PMID: 18957531 [PubMed - indexed for MEDLINE]Related articlesFree article

12.

Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.

Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.

Diabetes Care. 2004 Mar;27(3):765-9.PMID: 14988299 [PubMed - indexed for MEDLINE]Related articlesFree article

13.

GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications.

Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M.

Am J Gastroenterol. 2002 Mar;97(3):604-11.PMID: 11922554 [PubMed - indexed for MEDLINE]Related articles

14.

Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.

Nakamura A, Shikata K, Hiramatsu M, Nakatou T, Kitamura T, Wada J, Itoshima T, Makino H.

Diabetes Care. 2005 Dec;28(12):2890-5.PMID: 16306550 [PubMed - indexed for MEDLINE]Related articlesFree article

15.

Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study.

Schram MT, Chaturvedi N, Schalkwijk CG, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group.

Diabetologia. 2005 Feb;48(2):370-8. Epub 2005 Feb 4.PMID: 15692810 [PubMed - indexed for MEDLINE]Related articles

16.

Association between mannose-binding lectin and vascular complications in type 1 diabetes.

Hansen TK, Tarnow L, Thiel S, Steffensen R, Stehouwer CD, Schalkwijk CG, Parving HH, Flyvbjerg A.

Diabetes. 2004 Jun;53(6):1570-6.PMID: 15161763 [PubMed - indexed for MEDLINE]Related articlesFree article

17.

Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients.

Panero F, Novelli G, Zucco C, Fornengo P, Perotto M, Segre O, Grassi G, Cavallo-Perin P, Bruno G.

Diabetes Care. 2009 Feb;32(2):301-5. Epub 2008 Nov 18.PMID: 19017769 [PubMed - indexed for MEDLINE]Related articlesFree article

18.

The relationship of prorenin values to microvascular complications in patients with insulin-dependent diabetes mellitus.

Davies L, Fulcher GR, Atkins A, Frumar K, Monaghan J, Stokes G, Clifton-Bligh P, McElduff A, Robinson B, Stiel J, Twigg S, Wilmshurst E.

J Diabetes Complications. 1999 Jan-Feb;13(1):45-51.PMID: 10232709 [PubMed - indexed for MEDLINE]Related articles

19.

Type 1 diabetes mellitus in Catalonia: chronic complications and metabolic control ten years after onset.

Cantón A, Fernández Castańer M, Conget I, Carreras G, Castell C, Tresserras R.

Med Sci Monit. 2004 May;10(5):CR185-90. Epub 2004 Apr 28.PMID: 15114267 [PubMed - indexed for MEDLINE]Related articles

20.

Impact of overweight on chronic microvascular complications in type 1 diabetic patients.

De Block CE, De Leeuw IH, Van Gaal LF.

Diabetes Care. 2005 Jul;28(7):1649-55.PMID: 15983315 [PubMed - indexed for MEDLINE]Related articlesFree article

Supplemental Content

Filter your results:

Find related data

Recent activity